A COMPARATIVE STUDY ON THE EFFICIENCY OF PATOLADI GHRITA PANA AND PUNARNAVADHI ANJANA IN TIMIRA
DOI:
https://doi.org/10.70066/jahm.v7i2.58Keywords:
Timira, Patoladi ghrita, Punarnavadi Anjana, Senile cataractAbstract
Background: Senile cataract is an age related vision threatening disease. It affects 12 to 15 million persons worldwide. In India approximately 3.38 million persons become blind from cataract every year. Senile immature cataract closely resembles the symptoms of Timira involving Prathama and Dwithiya patala. At present there is no time tested and proven medical treatment to delay, prevent or reverse the development of senile cataract. The present research work is aimed to evaluate easy, cost effective and prevent the deterioration of sight. Aims: To evaluate the efficacy of Patoladi ghrita pana and Punarnavadi anjana in the management of Timira. Methods and Material: It isarandomized non-controlled parallel arm clinical study. A total of 40 patients who are fulfilling the diagnostic and inclusion criteria were selected randomly and allotted in to 20 patients in each group. Group ‘A’ patients weretreated with Patoladi gritha internally and Group ‘B’patients were treated with Punarnavadi Anjana external application. Statistical analysis used: The data were graded based on standard methods and analyzed statistically using Paired’t’and Unpaired’t’tests. Results: Both the groups have shown statistically significant results. Group B patients showed better response when compared to group A. Conclusion: Both medicines were found to be effective in reducing the severity of the symptoms but were not sufficient enough to improve the visual acuity to higher extent and density of opacity. Patients with immature cataract with short duration showed better response when compared to that of longer duration.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 PRADEEP KUMAR K

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.